RinGlar 100 U/mL

    RinGlar 100 U/mL — package

    info General information

    Name RinGlar, 100 U/mL, solution for subcutaneous administration
    INN Insulin glargine
    Active substance Insulin glargine
    Pharmacotherapeutic group Drugs used in diabetes. Insulins and analogues. Long-acting insulins and analogues for injection.
    Dosage form Solution for subcutaneous administration.
    Packaging

    3.0 mL in colorless glass cartridges.

    1. 5 cartridges in a blister pack. 1 blister pack is placed in a cardboard box.

    2. The cartridge is installed in a plastic multi-dose disposable pen injector for repeated injections, Rinastra II. 5 pre-filled multi-dose disposable pen injectors for repeated injections, Rinastra II, are placed in a cardboard box.

    Manufacturer Karaganda Pharmaceutical Complex LLP EU GMP

    assignment_turned_in Indications

    RinGlar is indicated for the treatment of diabetes mellitus requiring insulin therapy in adults, adolescents and children aged 2 years and older.